Congenital diaphragmatic hernia. Epidemiology and outcome

Area of Science:

• Pediatric Surgery
• Neonatology
• Birth Defects Research

Background:

• Congenital diaphragmatic hernia (CDH) is a significant birth defect impacting approximately 1114 infants annually in the U.S.
• Survival rates for CDH average 60%, with considerable institutional and geographical variability.
• The etiology of CDH remains largely unknown, with evidence suggesting multiple causative factors due to its association with other anomalies and diverse presentations.

Purpose of the Study:

• To address the lack of comparative data on CDH treatment efficacy.
• To establish a framework for stratifying CDH patients into more homogeneous groups for clinical trials.
• To initiate a multicenter data collection effort to facilitate research on CDH.

Main Methods:

• Formation of the Congenital Diaphragmatic Hernia Study Group, a multicenter collaborative.
• Initiation of prospective data collection to gather comprehensive information on CDH cases.
• Development of a patient stratification scheme as an initial research goal.

Main Results:

• CDH is a leading cause of perinatal morbidity and mortality.
• Significant variability exists in CDH treatment approaches and patient outcomes.
• Current data limitations hinder rigorous comparison of different treatment strategies.

Conclusions:

• CDH necessitates further investigation into its etiology and management.
• Multicenter collaboration is essential for conducting meaningful clinical trials in CDH.
• Stratification of CDH patients is a critical step toward improving treatment efficacy and outcomes.